Zobrazeno 1 - 10
of 117
pro vyhledávání: '"F. Le Pessot"'
National multicentric evaluation of quality of pathology reports for rectal cancer in France in 2016
Autor:
Anne Rullier, Céline Bazille, M. Desrousseaux, A. Daubech, Catherine Julie, F. Thélu, F. Le Pessot, B. Turlin, S. Stanislas, M.-S. Bordier, Armelle Bardier, C. Boutanos, Marie-Hélène Laverriere, R.-P. Eyremandi, A. Rousseau, T. Lazure, Janick Selves, Frédéric Bibeau, Nathalie Guedj, Magali Svrcek, M. Capdepont, Flora Poizat, B. Bonhomme, A. Demoures
Publikováno v:
Virchows Archiv
Virchows Archiv, Springer Verlag, 2019, 474 (5), pp.561-568. ⟨10.1007/s00428-019-02534-8⟩
Virchows Archiv, Springer Verlag, 2019, 474 (5), pp.561-568. ⟨10.1007/s00428-019-02534-8⟩
International audience; The quality of pathologic assessment of rectal cancer specimens is crucial for treatment efficiency and survival. The Royal College of Pathologists (RCP) recommends evaluating the quality of the pathology report in routine pra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac1f7d94ed30da7902adcfed18b4617
https://hal.umontpellier.fr/hal-02431858
https://hal.umontpellier.fr/hal-02431858
Publikováno v:
Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD).
Publikováno v:
Annales de Pathologie. 27:122-125
Autor:
I. Le Blanc-Louvry, B. Lefebure, B. Albouy, Jean-Jacques Tuech, F. Le Pessot, Francis Michot, Valérie Bridoux, Emilie Lermite
Publikováno v:
Journal of Gastrointestinal Surgery. 12:612-615
Indications for pancreatic resections for metastatic disease have not yet been defined to date, and few guidelines exist for the management of these lesions. However, most authors recommend surgery as the treatment of choice for pancreatic metastasis
Autor:
A. Lamy, Jean-Christophe Sabourin, Audrey Killian, Pierre Michel, Thierry Frebourg, L Bastit, F. Le Pessot, Bernard Paillot, Richard Sesboüé, F. Di Fiore, A.-M. Queuniet, Francis Michot, M.P. Galais, F. Blanchard, Jean-Jacques Tuech, Françoise Charbonnier
Publikováno v:
British Journal of Cancer
The predictive value of KRAS mutation in metastatic colorectal cancer (MCRC) patients treated with cetuximab plus chemotherapy has recently been suggested. In our study, 59 patients with a chemotherapy-refractory MCRC treated with cetuximab plus chem
Autor:
Stéphane Lecleire, Eric Lerebours, Guillaume Savoye, Michel Antonietti, F. Di Fiore, P. Ducrotté, F. Lemoine, F. Le Pessot
Publikováno v:
Endoscopy. 38:696-701
Background and study aims Celiac disease can manifest with nonspecific symptoms, including functional gastrointestinal disorders such as dyspepsia. The aim of our study was to assess the usefulness of duodenal endoscopic markers of villous atrophy fo
Autor:
Julia B. Winston, S Lejeune Dumoulin, Michael Lovett, Sérgio Castedo, Carla Oliveira, Juanliang Cai, Stéphanie Baert-Desurmont, Michel Scotté, C Marroni, Cosette Martin, José Carlos Machado, Michel Vekemans, Fátima Carneiro, Sylvie Manouvrier, Cláudio Osmar Pereira Alexandre, Rachid Karam, C. Graziadio, J P Triboulet, F Le Pessot, A Hedouin, A Hartmann, T Attié, P Hochain, Raquel Seruca, Ph Pellerin, Thierry Frebourg, Martine Blayau, Ethylin Wang Jabs
Publikováno v:
Journal of Medical Genetics. 43:138-142
We report the association of CDH1/E‐cadherin mutations with cleft lip, with or without cleft palate (CLP), in two families with hereditary diffuse gastric cancer (HDGC). In each family, the CDH1 mutation was a splicing mutation generating aberrant
Publikováno v:
Annales de Pathologie. 27:85-87
Autor:
Gaëlle Bougeard, F. Boissière, Jean-Jacques Tuech, J.-C. Sabourin, Frédéric Bibeau, Marc Ychou, David Tougeron, Françoise Charbonnier, Pierre Michel, F. Le Pessot, Aude Lamy, Thierry Frebourg, F. Di Fiore, Alice Oden-Gangloff, F. Blanchard
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 2009, 100 (8), pp.1330-1335. ⟨10.1038/sj.bjc.6605008⟩
British Journal of Cancer, Cancer Research UK, 2009, 100 (8), pp.1330-1335. ⟨10.1038/sj.bjc.6605008⟩
British Journal of Cancer, 2009, 100 (8), pp.1330-1335. ⟨10.1038/sj.bjc.6605008⟩
British Journal of Cancer, Cancer Research UK, 2009, 100 (8), pp.1330-1335. ⟨10.1038/sj.bjc.6605008⟩
International audience; Recent studies have suggested that activation of the EGFR pathway leads to malignant transformation only if the p53 protein is inactivated. Therefore, we evaluated the impact of TP53 mutations on cetuximab-based chemotherapy (
Autor:
I. Iwanicki-Caron, Stéphane Lecleire, C. Elie, Pierre Michel, P. Ducrotté, F. Di Fiore, F. Lemoine, F. Le Pessot, Michel Antonietti
Publikováno v:
Endoscopy. 41